Butterfly Network Operating Income 2020-2023 | BFLY

Butterfly Network operating income from 2020 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Butterfly Network Annual Operating Income
(Millions of US $)
2023 $-146
2022 $-193
2021 $-193
2020 $-162
2019 $-102
Butterfly Network Quarterly Operating Income
(Millions of US $)
2023-12-31 $-47
2023-09-30 $-33
2023-06-30 $-31
2023-03-31 $-35
2022-12-31 $-49
2022-09-30 $-46
2022-06-30 $-48
2022-03-31 $-50
2021-12-31 $-45
2021-09-30 $-57
2021-06-30 $-37
2021-03-31 $-54
2020-12-31 $-22
2020-09-30 $-92
2020-06-30 $-23
2020-03-31 $-25
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.162B $0.066B
Butterfly Network Inc. created handheld, single-probe whole-body ultrasound system, Butterfly iQ. The company through its proprietary Ultrasound-On-Chip(TM) technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions. Butterfly Network Inc., formerly known as Longview Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $34.790B 19.11
Inspire Medical Systems (INSP) United States $7.322B 0.00
10x Genomics (TXG) United States $3.489B 0.00
IRhythm Technologies (IRTC) United States $3.410B 0.00
Axonics (AXNX) United States $3.396B 0.00
Enovis (ENOV) United States $3.029B 23.01
Azenta (AZTA) United States $2.925B 238.46
Olink Holding AB (publ) (OLK) Sweden $2.864B 0.00
Hims & Hers Health (HIMS) United States $2.685B 0.00
Privia Health (PRVA) United States $2.183B 96.84
Schrodinger (SDGR) United States $1.763B 0.00
Omnicell (OMCL) United States $1.231B 30.12
Phreesia (PHR) United States $1.169B 0.00
Definitive Healthcare (DH) United States $0.817B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.783B 0.00
Standard BioTools (LAB) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.608B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.367B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.333B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.293B 0.00
P3 Health Partners (PIII) United States $0.170B 0.00
American Well (AMWL) United States $0.148B 0.00
MSP Recovery (LIFW) United States $0.139B 0.00
Augmedix (AUGX) United States $0.133B 0.00
Outset Medical (OM) United States $0.131B 0.00
TruBridge (TBRG) United States $0.116B 4.94
111 (YI) China $0.087B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
SHL Telemedicine (SHLT) Israel $0.071B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
Movano (MOVE) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.022B 0.00
CareCloud (CCLD) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00